These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15678700)

  • 1. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.
    Engellau J
    Acta Orthop Scand Suppl; 2004 Dec; 75(314):2 p preceding table of contents-52, backcover. PubMed ID: 15678700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
    Engellau J; Bendahl PO; Persson A; Domanski HA; Akerman M; Gustafson P; Alvegård TA; Nilbert M; Rydholm A
    Hum Pathol; 2005 Sep; 36(9):994-1002. PubMed ID: 16153463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
    Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
    Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
    Gustafson P
    Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
    Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
    Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
    Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
    J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
    Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
    Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD100 expression in soft tissue sarcoma.
    Ch'ng E; Tomita Y; Zhang B; He J; Hoshida Y; Qiu Y; Morii E; Nakamichi I; Hamada K; Ueda T; Aozasa K
    Cancer; 2007 Jul; 110(1):164-72. PubMed ID: 17520683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should tumor depth be included in prognostication of soft tissue sarcoma?
    Rydholm A; Gustafson P
    BMC Cancer; 2003 May; 3():17. PubMed ID: 12769830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
    Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
    Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
    Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
    Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
    Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
    Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas.
    Mertens F; Strömberg U; Rydholm A; Gustafson P; Bauer HC; Brosjö O; Mandahl N
    J Clin Oncol; 2006 Jan; 24(2):315-20. PubMed ID: 16330667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas.
    Eilber FC; Brennan MF; Riedel E; Alektiar KM; Antonescu CR; Singer S
    Ann Surg Oncol; 2005 Mar; 12(3):228-36. PubMed ID: 15827815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44s expression is associated with improved survival in soft tissue sarcoma.
    Peiper M; Sato T; Zurakowski D; Eisenberger C; Heinecke A; Hosch S; Knoefel WT
    Anticancer Res; 2004; 24(2C):1053-6. PubMed ID: 15154622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.